NCT07144839 Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation
| NCT ID | NCT07144839 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oregon Health and Science University |
| Condition | Stillbirth |
| Study Type | OBSERVATIONAL |
| Enrollment | 640 participants |
| Start Date | 2025-09-18 |
| Primary Completion | 2029-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 640 participants in total. It began in 2025-09-18 with a primary completion date of 2029-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective observational study with the goal of developing and assessing a predictive model of placental insufficiency.
Eligibility Criteria
Inclusion Criteria: * Pregnant * Age 15 or older * No known major fetal anatomic or genetic abnormalities * Singleton gestation * Planning to deliver at Oregon Health \& Science University * Prior to 22 weeks' gestation Exclusion Criteria: * Decisional impairment * Multiple gestation * Known fetal growth restriction or major congenital anomaly * Inability to consent * Inability to attend study visits
Contact & Investigator
Karen Gibbins
PRINCIPAL INVESTIGATOR
Oregon Health and Science University
Frequently Asked Questions
Who can join the NCT07144839 clinical trial?
This trial is open to female participants only, aged 15 Years or older, up to 50 Years, studying Stillbirth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07144839 currently recruiting?
Yes, NCT07144839 is actively recruiting participants. Contact the research team at whru@ohsu.edu for enrollment information.
Where is the NCT07144839 trial being conducted?
This trial is being conducted at Portland, United States.
Who is sponsoring the NCT07144839 clinical trial?
NCT07144839 is sponsored by Oregon Health and Science University. The principal investigator is Karen Gibbins at Oregon Health and Science University. The trial plans to enroll 640 participants.